Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacteria that act as wound pathogens are a diverse group of microorganisms capable of colonizing and infecting wounds, leading to delayed healing, local tissue damage, and sometimes systemic infection. These bacteria can be aerobic or anaerobic and often originate from the skin, mucosal surfaces, or the environment. Common species include Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterococcus faecalis, Acinetobacter baumannii, Escherichia coli, Proteus mirabilis, and Streptococcus pyogenes. Pathogenic mechanisms include adherence to host tissues, production of toxins, and formation of biofilms. Many common wound pathogens exhibit multidrug resistance, posing challenges for effective treatment.
Antibiotics target bacterial cell wall synthesis, protein synthesis, DNA replication, or other essential bacterial processes. Antiseptics disrupt bacterial cell membranes and denature proteins.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacteria (Wound Pathogens).